Related Experiment Video
Updated: May 14, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
[Pregnancy and systemic lupus erythematosus: compatible?]
M Jason1, C von Frenckell, P Emonts
1Université de Liège, Belgique.
Revue Medicale De Liege
|January 26, 2013
Summary
Systemic lupus erythematosus (SLE) in pregnant women poses significant risks for both mother and child. However, with careful management and advances in understanding, most SLE pregnancies now conclude successfully.
Area of Science:
- Obstetrics and Gynecology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease primarily affecting women of childbearing age.
- Pregnancy in women with SLE presents elevated risks for obstetric complications and potential disease flares.
Observation:
- SLE pregnancies are classified as high-risk, necessitating close collaboration between obstetricians and rheumatologists.
- Pregnancy can trigger SLE disease activity, potentially requiring immunosuppressive treatments.
Findings:
- Despite inherent risks, advancements in medical understanding and collaborative care have improved outcomes for SLE pregnancies.
- Most pregnancies in women with SLE now result in successful deliveries.
Implications:
- Highlights the critical importance of multidisciplinary care in managing high-risk pregnancies.
- Emphasizes the positive impact of ongoing research and improved understanding of the mother-child relationship in SLE.
- Suggests a favorable outlook for SLE parturients with appropriate medical supervision.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...